

Publisher: Bentham Science Publishers
E-ISSN: 1875-6638|11|1|13-20
ISSN: 1573-4064
Source: Medicinal Chemistry, Vol.11, Iss.1, 2015-02, pp. : 13-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Derivatives of quinoxalinedione (QX) were chosen as chemical lead for the development of new radioligands of the AMPA receptor, since there are several examples of QX-derivatives with high affinity. The radiosyntheses of the new compounds 6-[18F]fluoro-7-nitro-QX ([18F]FNQX) and 7-[18F]fluoro-6-cyano-QX ([18F]FCQX) with radiochemical yields of 8 ± 2 and 3 ± 2 %, respectively, as well as the evaluation of their binding properties to the AMPA-receptor were performed. A comparison of the Ki-values of the new QX-derivatives FCQX and FNQX with mono-substituted cyanoand nitro-QX shows negligibly small differences of affinity (within the range of 1.4 to 5 µM), but exhibits a tenfold lower affinity than derivatives with two electron withdrawing groups like the 7-cyano-6-nitro-compound CNQX and the 6,7- dinitro compound DNQX. Thus, with respect to the low affinity and a high non-specific binding with in vitro and ex vivo autoradiographic studies, the new compounds do not lend themselves for in vivo imaging.
Related content


Current Pharmaceutical Biotechnology, Vol. 11, Iss. 6, 2010-01 ,pp. :






By Chimirri A. Gitto R. Zappalà M.
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. :


Current Medicinal Chemistry, Vol. 8, Iss. 2, 2001-02 ,pp. :